Effect of sildenafil on haemodynamic response to exercise and exercise capacity in Fontan patients.
about
Safety and tolerability considerations in the use of sildenafil for children with pulmonary arterial hypertensionHypoplastic left heart syndrome: current considerations and expectationsDrug treatment of pulmonary hypertension in childrenAssessment of Quality of Life in Young Patients with Single Ventricle after the Fontan OperationClinical research priorities in adult congenital heart diseaseLaboratory measures of exercise capacity and ventricular characteristics and function are weakly associated with functional health status after Fontan procedure.The use of Macitentan in Fontan circulation: a case report.The Fontan pathway: What's down the road?What Limits Cardiac Performance during Exercise in Normal Subjects and in Healthy Fontan Patients?The effect of bosentan on exercise capacity in Fontan patients; rationale and design for the TEMPO study.Impact of oral sildenafil on exercise performance in children and young adults after the fontan operation: a randomized, double-blind, placebo-controlled, crossover trialEffect of inhaled iloprost on the exercise function of Fontan patients: a demonstration of conceptEstimating equations for cardiopulmonary exercise testing variables in Fontan patients: derivation and validation using a multicenter cross-sectional database.A consensus approach to the classification of pediatric pulmonary hypertensive vascular disease: Report from the PVRI Pediatric Taskforce, Panama 2011.Pharmacokinetics of intravenous sildenafil in children with palliated single ventricle heart defects: effect of elevated hepatic pressures.The importance of the muscle and ventilatory blood pumps during exercise in patients without a subpulmonary ventricle (Fontan operation)Effect of Sildenafil on Pressure-Volume Loop Measures of Ventricular Function in Fontan PatientsMagnetic resonance imaging catheter stress haemodynamics post-Fontan in hypoplastic left heart syndromeTreatment of heart failure in adult congenital heart disease: a position paper of the Working Group of Grown-Up Congenital Heart Disease and the Heart Failure Association of the European Society of Cardiology.Response to a single dose of sildenafil in single-ventricle patients: an echocardiographic evaluation.Endothelial Function and Arterial Stiffness Relate to Functional Outcomes in Adolescent and Young Adult Fontan SurvivorsA simulation protocol for exercise physiology in Fontan patients using a closed loop lumped-parameter model.Current challenges in pediatric pulmonary hypertension.Sildenafil in the management of the failing Fontan circulation.Liver disease in the patient with Fontan circulation.Modulation of pulmonary vascular resistance as a target for therapeutic interventions in Fontan patients: focus on phosphodiesterase inhibitors.Impact of pulmonary vascular resistances in heart transplantation for congenital heart disease.Heart Failure in Adults who had the Fontan Procedure: Natural History, Evaluation, and Management.Pulmonary hypertension related to congenital heart disease: a call for action.Pulmonary hypertension in adults with congenital heart disease and Eisenmenger syndrome: current advanced management strategies.Heart failure treatment in adults with congenital heart disease: where do we stand in 2014?Sildenafil for the treatment of pulmonary hypertension in children.Pulmonary vasodilator therapy in the failing Fontan circulation: rationale and efficacy.Longitudinal Outcomes of Patients With Single Ventricle After the Fontan Procedure.Results of a phase I/II multi-center investigation of udenafil in adolescents after fontan palliation.Drug therapy in the prevention of failure of the Fontan circulation: a systematic review.The Long-Term Management of Children and Adults with a Fontan Circulation: A Systematic Review and Survey of Current Practice in Australia and New Zealand.Managing heart failure in adults with congenital heart disease.Impact of oral chronic administration of sildenafil in children and young adults after the Fontan operation.Impact of vitamin C on endothelial function and exercise capacity in patients with a Fontan circulation.
P2860
Q26771505-9814910A-6AAC-4A3B-861D-6CCF164FAEBEQ26821904-E597BC9C-AE20-4F4D-A6D3-97C1FA647649Q26996078-6EA09BA3-FE2A-475E-BC68-15915DE17236Q30353923-F4B00854-12EC-4E86-B042-FEE820319D9CQ30418760-6D9FFABC-5A7C-461B-82BE-58EC2384B303Q33606969-D5AC7104-0381-4844-ACF8-4AC8CB05F243Q33717010-237ED555-40A6-4A06-B42B-584A72D2D648Q33735733-18ED7DEB-E175-4AA0-8EFB-27D6315F8947Q34143478-742BD283-811E-4B66-8A14-4B1A6D982F77Q34714775-66622B21-6F90-4034-A7E4-40AF8DC32E4BQ34775696-A2458E11-98B6-4D1D-92D0-1AEF2A08A02CQ34890485-C4948268-C480-42AA-9C52-100D314877A7Q35181093-94A18893-9A70-458B-B446-34DAC4C0C4DFQ35181115-76678F87-AC24-4462-AFE9-D4041F0073CAQ36113640-67309F45-85C7-4531-A486-699E22D69839Q36797220-BDFE2227-129C-4680-BD96-28B4F803D5F8Q36802908-1AC10838-E6FC-46BB-9AEB-4B1A0DCC0E7DQ36912434-1E35CAFE-D161-4D99-A769-13E3A115360FQ37023891-D8344090-FDF8-42C6-AE21-3D44C463E037Q37198633-831EAEDD-F84F-4938-8F35-678CE89F3759Q37364529-29AB6694-F858-420A-8797-BB1C3175B6CEQ37401796-9A552F1E-DCB3-4F64-BF36-47F48E1094DDQ37540613-E0067B68-7ECD-45DA-9F58-D30B12E75985Q37762313-2820D632-3754-4D43-9552-4463A0BA466AQ37858605-CDA25B7D-FEBE-4962-9728-AC77A35F2F92Q37993150-B1312CDC-E55F-449D-BA98-85F623B27347Q38006697-AF7C761F-6297-4967-9391-A5BD90554E80Q38126437-AC168C8C-E0FA-47ED-8627-03B13DE436FBQ38156253-43F7DC0D-3A06-4514-9CBD-1E9AC9D443A1Q38211843-BBF866EB-8A9E-4CBB-BC1A-CCBA8B42D3DBQ38219870-BA3C19FD-60A9-4530-93F2-12C6D3837217Q38249704-59121C9A-567B-41AA-A642-C0C08460DD54Q38671350-A1826F98-B84B-4658-AC72-D419B24B48D1Q38676076-F177EE20-56CD-4314-BC03-CD934A8952CFQ38746984-1E39C4F3-FBEA-4A55-B820-0F67408EB723Q38762647-EA5DA488-A364-4E86-BA66-43A96572068AQ38804287-0D19A975-DEA8-4949-A1BA-3D215C50C008Q39036971-34CFBF52-35B3-47A5-A582-611A0055BC08Q39706269-6D2CCCC8-C2E7-4E92-8096-EF7F5473715AQ40012473-C1CA9F04-2C0E-489B-8EBD-D75F62A2778C
P2860
Effect of sildenafil on haemodynamic response to exercise and exercise capacity in Fontan patients.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Effect of sildenafil on haemod ...... e capacity in Fontan patients.
@en
Effect of sildenafil on haemod ...... e capacity in Fontan patients.
@nl
type
label
Effect of sildenafil on haemod ...... e capacity in Fontan patients.
@en
Effect of sildenafil on haemod ...... e capacity in Fontan patients.
@nl
prefLabel
Effect of sildenafil on haemod ...... e capacity in Fontan patients.
@en
Effect of sildenafil on haemod ...... e capacity in Fontan patients.
@nl
P2093
P356
P1476
Effect of sildenafil on haemod ...... e capacity in Fontan patients.
@en
P2093
Alessandro Giardini
Anna Balducci
Fernando Maria Picchio
Salvatore Specchia
P304
P356
10.1093/EURHEARTJ/EHN215
P577
2008-06-04T00:00:00Z